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Abstract 
Objective 
The hidden web is used for the anonymous sale of drugs, and with the UK Psychoactive 
Substances Act, 2016 implemented on May 26th 2016; it could increase as a platform for 
obtaining new psychoactive substances (NPS). 
This study aims to describe the NPS market on the visible and hidden web pre-ban, and 
assess whether the hidden web is a likely place for the sale of NPS post-ban. 
Methods 
Data collection of 113 online shops took place in October 2015. Data collection of 22 
cryptomarkets took place every two months from October 2015-16 as part of the 
CASSANDRA project.  
Results 
All online shops with a UK domain location sold NPS that were uncontrolled by the UK 
Misuse of Drugs Act, 1971 and closed after the ban. Of the cryptomarkets analysed, the total 
number of vendors selling NPS, number of substances, and listings advertised, all increased 
over the year. The majority of the NPS advertised on the hidden web were phenethylamines 
and cathinones, yet the majority of uncontrolled NPS were synthetic cannabinoids.  
Conclusions 
Vendors selling and availability of NPS increased over the 12 months of data collection. 
Potential displacement from the visible web to hidden web should be taken into 
consideration. 
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Introduction 
The Internet has a major role in the sale and distribution of new psychoactive substances 
(NPS) (Hillebrand, Olszewski & Sedefov, 2010; Schmidt, Sharma, Schifano & Feinmann, 
2011). However, the availability and movement of NPS from when they first appear on the 
market until they are controlled under international and/or national drug laws or disappear 
from the market is under researched. NPS are sold online, often passed off as ‘research 
chemicals’ and ‘legal highs’, in shops that can be accessed through ordinary search engines 
such as GoogleTM or BingTM. In 2013, there were found to be 651 online shops selling NPS 
that purportedly shipped to Europe (EMCDDA, 2011). Here, the products vary according to 
manufacturer’s availability and/or legislation (Smith & Garlich, 2013). In addition to the 
supply on the visible web, NPS can be purchased on the hidden web, an online network that 
cannot be accessed by regular search engines, but only with encryption software, such as 
the Onion Router (Tor) (Tor Project, 2016). On the hidden web, drugs are sold through 
cryptomarkets, which are platforms that use anonymous cryptocurrencies and where users 
can leave reviews of vendors and the products (Barratt, 2012; Seddon, 2014; Van Hout & 
Bingham, 2014). Research shows that it is predominantly illicit controlled drugs and 
medicines which are purchased through this market (Barratt, Ferris, & Winstock, 2014; 
Caudevilla et al, 2016). However, it remains only a small portion of the overall drugs market 
(EMCDDA & Europol, 2016). One of the best-known cryptomarkets was Silk Road, which 
closed in 2013 (DEA, 2013). Since the closure, there is no obvious market leader and the 
hidden web now has a wide range of retailers (Van Buskirk, Roxburgh, Farrell, & Burns, 
2014; Van Buskirk, Roxburgh, Bruno & Burns, 2015). Cryptomarkets can be unpredictable 
and close down with little notice causing instability in the market (Van Buskirk, et al., 2015). 
The UK has the highest number of vendors in Europe, and ranked second in the world 
(Kristy et al, 2016). 
There is mixed evidence on the extent to which the Internet is used for purchasing NPS. The 
estimate from various studies in the UK and Europe, is that one in ten purchasers will buy 
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their NPS products online (European Commission, 2014; Home Office, 2014a). In a self-
selected population in the Global Drugs Survey, it was found that in 2013/14, 22.1% of 
responders bought their NPS online (Winstock, 2014). There are benefits to both buyers and 
sellers who use the Internet for the sale of drugs, such as anonymity and the removal of 
face-to-face contact (Van Hout & Bingham, 2013). It is important to note that it is not only 
NPS for personal use that can be bought via the Internet, NPS can be bought in bulk and 
distributed further among social circles and street level drug dealers (EMCDDA, 2013).  
With the increasing concern of the growth of the NPS market, the UK Government 
introduced the Psychoactive Substances Act, 2016 on the 26th May 2016. The Act controls 
all psychoactive substances (with some exemptions), that are not already controlled by UK’s 
principal drug law the Misuse of Drugs Act, 1971 (UK Government, 2016), by prohibiting 
unlicensed supply and production. Possession under the Act is not an offence (except in a 
custodial institution).  
NPS that are not controlled under drug laws are desirable to both the suppliers and users, 
such as experimentation and production without fear of incarceration (Brandt, Sumnall, 
Measham, & Cole, 2010). Once a substance is controlled by international and/or national 
drug laws, one study found that interest in that drug declines (Ledberg, 2015). Research has 
found that displacement of drugs from one supplier to another, for example from high-street 
retailer to street-level drug dealer, is reflective of its legal status (Sumnall, Evans‐Brown, & 
McVeigh, 2011). This has been the case with mephedrone, where it transitioned from online 
and high-street retail suppliers to street level drug dealers once it became a class B drug 
under the Misuse of Drugs Act, 1971 (EMCDDA, 2013). The Psychoactive Substances Act, 
2016 was implemented with the intent of reducing the supply of NPS from online and high-
street retail shops, and thus removed two principal supply routes of NPS (Home Office, 
2015). But it is possible that a displacement has occurred instead between the visible and 
the hidden web for the sale of NPS after the implementation of the Act with little or no 
reduction in overall supply. There is currently insufficient data to assess the potential impacts 
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of the Act. Further, research to date has not focused specifically on the availability of NPS on 
the cryptomarkets, especially during a time of policy change. This paper therefore aims to: i. 
describe the markets for NPS on the visible and hidden web up to seven months before the 
implementation of the Psychoactive Substances Act, 2016; ii. consider the impact of the 
Psychoactive Substances Act, 2016 on the supply of the NPS after implementation, through 
number of vendors and available substances. 
Methods 
The data collection both on the visible and hidden web were carried out by the first author 
(EW) between October 2015 and October 2016; that is seven months prior to the 
Psychoactive Substances Act, 2016 and five months after the implementation. The study is 
part of the CASSANDRA project (www.projectcassandra.eu). 
Data collection on the visible web 
The search for online retailers selling NPS were made throughout October 2015. Search 
engine’s Google™ and Bing™ were used and various keywords were chosen to extract 
retailers including “buy” followed by “legal highs”; “research chemicals”; “bath salts”; “party 
pills”; or, “herbal highs” (table 1).  
<INSERT TABLE 1 HERE> 
For every keyword, the first five pages of results were used, and those in the English 
language were extracted. Data collected from the websites included: types of NPS sold; last 
update of website; the country of domain; countries of distribution; and whether the company 
sold wholesale.  
Data collection on the hidden web 
The data collection on the cryptomarkets took place over two days in each month in October, 
December (2015), February, April, June, August and October (2016). The cryptomarkets 
were accessed through Tor. The cryptomarkets that were included were those in the English 
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language, sold NPS, and had an open registration to all. The marketplaces are shown in 
table 2. Certain cryptomarkets closed before data collected commenced such as Abraxas. In 
addition, other cryptomarkets opened or expanded to sell NPS during the data collection. 
Some cryptomarkets were inaccessible during periods of data collection but not suggested 
to have closed completely such as DrD’s Marketplace, which was not accessible for data 
collection in June and October 2016.  
<INSERT TABLE 2 HERE> 
Data were collected on each cryptomarket of NPS advertised that were visible to the 
researcher. Data collected were: Name of NPS (not including illicit drugs, human 
enhancement drugs or medicines), name of vendor, whether the vendor sold illicit controlled 
substances, and the countries of distribution. It should be noted that the frequency of the 
specific NPS advertised was determined by the number of vendors advertising and the 
number of listings of that product. 
Available substances were categorised based on chemical structure into 9 categories 
(EMCDDA, 2015): 
1. Dissociatives 
2. Benzodiazepine analogues 
3. Cathinones  
4. Opioids 
5. Phenethylamines 
6. Piperazines 
7. Synthetic cannabinoids 
8. Tryptamines 
9. Others/Unspecified 
Analysis was conducted using SPSS Statistics version 22 using descriptive analyses in form 
of frequencies and means as appropriate.  
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Ethical considerations 
The research was observational and did not involve interaction with either buyers or sellers. 
All users on cryptomarkets use screen names and are anonymous. Confidentiality measures 
applied to the dataset included storage in an online, password-protected computer and 
removal of screen pseudonyms, URLs, and country identifiers. The study was approved by 
King’s College London PNM Research Ethics reference number: LRS-15/16-3084 as part of 
the CASSANDRA project. 
Results 
Shops on the visible Internet 
A total of 113 shops selling NPS on the Internet were found in the English language. 
Substances were sold in different forms, some were powders, herbal incense or pellets, and 
some were in branded packages, such as ‘Gogaine’ or ‘Charly Sheen’. The branded NPS 
tended to display a similar combination of substances in varying ratios. Only 13% of shops 
(n=15) sold all forms of NPS. Out of 113 shops monitored, party pills or pellets were the 
most common form of NPS and were sold in 81% of shops.  
The online shops varied in the number of NPS that were sold, with a range of 180, and a 
mean of 37.5 (SD= 45.4) (when treating branded NPS as individual NPS).   
Shops were explored to see whether in addition to individual sale, they also offered 
wholesale, selling large quantities at a lower price. A majority of 55% of websites sold 
wholesale, whereas the remaining websites did not advertise the option. 
All substances sold on the visible web with a UK domain were not controlled under the 
Misuse of Drugs Act, 1971 at the time of data collection. They included but were not limited 
to: Mexedrone, 1P-LSD, 3F-Phenmetrazine, bk-2C-B, diphenidine, MDAI, and AB-
CHMINACA. Substances that were pending control, such as methiopropamine (MPA), were 
advertised with a discount price and highlighted that ‘all stock must go’. Shops appeared to 
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be aware of changes in legislation and remove substances that were pending control. The 
market seemed to respond by introducing new substances with similar effects.  
Shops promoted new substances as alternatives of popular NPS. For example the following 
is a description of Mexedrone from the website RapidChems (rapidchems.com/en/):  
“The result is a product that’s similar in effect to 4-MMC aka Mephedrone [controlled 
under the Misuse of Drugs Act, 1971]. It's a bit weaker and a bit more material is 
needed for the desired result in your lab experiments but it’s clearly the most similar 
thing to MMC and we think the best product in its category right now.” 
Of the 46 unique substances that were sold on the Internet online shops and from a domain 
location in the UK, 76% of substances were also sold on the hidden web. Online shops with 
a UK domain location closed prior to the implementation of the Psychoactive Substances 
Act, 2016, and after the 26th of May, only 57% (n=64) of the shops were still operational. In 
some cases shops notified customers of their pending closure, and in other cases they 
simply disappeared. The remaining shops were headshops or located overseas. 
Cryptomarkets 
Over the 12 months of data collection, 22 cryptomarkets were included. Over the course of 
the data collection, ten new marketplaces selling NPS opened and six were shut down, with 
suspicions of financial scams.  
From conducting the snapshots in two month intervals, the marketplaces included differed 
from month to month (table 2). The cryptomarket with the highest number of vendors selling 
NPS was not stable in the initial months, however AlphaBay retained the lead since 
February (table 3). The total number of vendors selling NPS, the total number of substances 
(controlled), and listings advertised all increased over the 12 months (74.5%, 93.6% and 
132.3% respectively). The total number of uncontrolled substances advertised increased in 
the months preceding the implementation of the ban (73.1% increase). The leading NPS 
category alternated between cathinones and phenethylamines.   
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<INSERT TABLE 3 HERE> 
Similar to the marketing techniques used on the visible web, vendors on the cryptomarkets 
used popular drugs to promote new stock, both controlled and uncontrolled. The following 
example was from cryptomarkets Valhalla (valhallaxmn3fydu.onion) and described the NPS 
“4-LPT”: 
“Dear Sirs, This is a new product developed as an alternative to A-PVP [controlled], a 
white powder, purity 99.8%, its effect is very good, but there is no market visibility, so 
now small sample sales, I believe it will quickly make you more satisfied than the a-
PVP, about its structural formula, as a trade secret, being confidential, look forward 
to working with you.” 
Discussion 
NPS were advertised on both the visible and hidden web, and almost all unique substances 
sold on the visible web were also available on the hidden web. The number of NPS 
advertised had increased over 12 months of data collection on the cryptomarkets for 
substances that are both controlled and uncontrolled (up to 26th May 2016) by the UK 
Misuse of Drugs Act, 1971. The growth of the NPS market on the hidden web suggests that 
the platform was capable for the displacement of drugs from online shops and high-street 
retailers, once the Psychoactive Substances Act, 2016 was established.  
A total of 113 shops in the English language were found on the visible web selling NPS in 
different forms, such as powders and pellets. Just over half of the online shops were selling 
substances at wholesale. Wholesale may point in the direction of further distribution, and 
displacement to the street level drug dealer and through social networks (Home Office, 
2014c). All substances found on the visible web, that held a UK domain, were not controlled 
under the Misuse of Drugs Act, 1971 at the time of data collection. After the implementation 
of the Psychoactive Substances Act, 2016, the UK shops either closed down, or relocated 
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overseas (Wadsworth, submitted). This mirrors what was found in a Home Office report, that 
some types of suppliers keep within the law and remove substances once controlled (Home 
Office, 2014b). Before the 26th May 2016, on the hidden web up to 31% of individual NPS 
advertised were not controlled in the UK and the majority were synthetic cannabinoids. 
However, the majority of overall substances sold were phenethylamines and cathinones. 
This is potentially due to both phenethylamines and cathinones having generic legislation in 
the Misuse of Drugs Act, 1971 rendering the majority controlled (ACMD, 2010).  
Phenethylamines were not as frequently described in literature as a popular class of NPS, 
and the most popular class of compounds were synthetic cannabinoids and cathinones 
(EMCDDA, 2015; Papaseit, Farré, Schifano, & Torrens, 2014; Zawilska & Andrzejczak, 
2015). 
On both the online shops and cryptomarkets, NPS were promoted as alternatives to popular 
illicit controlled drugs, which mirror what was found in previous studies (Brandt, et al., 2010). 
However, perhaps once all substances are controlled (with exemptions) and hold the same 
offences except possession, users may prefer to revert back to the original controlled drug 
(EMCDDA & Europol, 2016). Research has shown that in free market conditions, many 
users will choose well-established drugs over NPS (Caudevilla, 2014; Caudevilla et al, 
2016).  
A general instability of the cryptomarkets was observed throughout the data collection 
period. Over the course of the 12 months covered in this study, six markets closed due to 
suspected “exit scams” and ten new markets opened or begun advertising NPS. This only 
included the markets within the inclusion criteria, suggesting that even more may have 
opened and closed. The instability may deter buyers and sellers (Van Buskirk, et al., 2016), 
however replacement markets appear quickly and therefore the overall market exhibits 
resilience (Soska & Christin, 2015).  
Over a period of 12 months, there was an increase in the number of vendors selling NPS 
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and the number of unique NPS being advertised. The number of uncontrolled substances 
advertised increased until April 2016 where it plateaued. The use of cryptomarkets for the 
sale of NPS had increased substantially in this short amount of time. It further supports the 
suggestion that the hidden web is a growing market in an increasingly technology-advanced 
society. There is mixed evidence to how much the Internet, including the hidden web, are 
used to purchase NPS or drugs as a whole (European Commission, 2014; Winstock, 2014), 
but there is evidence to suggest its use is increasing amongst some drug-taking populations 
(Winstock, 2015). The hidden web is suited to specific populations such as the more tech-
savvy (Aldridge & Décary-Hétu, 2014). As such, displacement will most likely not be 
complete, as accessing the hidden web requires more skill than the online shops on the 
visible web. Further, specific populations that use high-street retailers, such as the 
homeless, may not have access to a computer or cryptocurrencies in order to visit 
cryptomarkets. However, there is a platform on the hidden web that is capable for the 
displacement of NPS for those that can use it.  
Future research should explore to what extent the NPS market is displaced to the hidden 
web, and if so, does it remain. Although the cryptomarkets are a small portion of the drugs 
trade, there is potential for its increase in use. A recent report by RAND Europe (Kristy et al, 
2016) stated that the evolution of the use of cryptomarkets was one of incremental and not 
explosive change. It was also found that listings have increased at a faster rate than 
transactions, suggesting that so far demand has not matched up to drug availability. Using 
the hidden web brings many benefits for the supplier and buyer that cannot be done via 
street level drug dealers. Communication can be made through encrypted messages that 
makes it more difficult for law enforcement to intercept (Van Hout & Bingham, 2014). 
Distribution is more effective, the mail service can be maximised, which would reduce the 
need for human distribution (Walsh, 2011). The sheer number of cryptomarkets operating 
with a high turnover shows that there is a demand for this type of drug market (Broséus, et 
al., 2016).   
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LIMITATIONS 
The number of online shops found in this study (n=113) is lower than the snapshots provided 
by the EMCDDA (n=651) (EMCDDA, 2011). However, the methods used in this study on 
used stores in the English language and capped the results at five pages in GoogleTM and 
BingTM search engines, which did not capture less popular online stores or those that did not 
come up in the search using the key words. For an overview of NPS sold on the visible web, 
113 online shops were found to be sufficient for this purpose.  
Another limitation to this study is that the data taken from the cryptomarkets were from what 
was advertised and does not represent data on how much was sold of each individual 
substance and received by buyers. However, it can be presumed that if the product is 
advertised, there is at least some availability from vendors and sufficient demand from users, 
which is what this study focuses on. In addition, this study did not purchase NPS from the 
cryptomarkets or test their contents. 
This study collected data at seven snapshots over a time period of 12 months; due to the 
inconsistency and instability of the cryptomarkets more frequent snapshots over a longer 
period of time are perhaps advantageous.  
CONCLUSION 
The cryptomarkets are an emerging source of sale for NPS. With the online sales on both 
the visible and hidden web holding a substantial portion of the market, NPS sold on the 
cryptomarkets should be monitored after the implementation of the Psychoactive 
Substances Act, 2016. Before the ban, up to 31% of monitored drugs in this study sold on 
the hidden web were uncontrolled in the UK, and the total number of vendors selling NPS, 
the total number of substances (controlled), and listings advertised all increased over this 
relatively short time frame (74.5%, 93.6% and 132.3% respectively). Regardless of these 
numbers, the demand and sales of NPS on the cryptomarkets are limited compared to 
‘classic’ controlled drugs such as cannabis and MDMA (Caudevilla, 2014). Furthermore, in a 
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recent report by the EMCDDA it was suggested that the reason for the low sales was due to 
their availability over the visible web (EMCDDA & Europol, 2016). With the reduction of NPS 
sales on the visible web and headshops, at least in the UK, this further supports the need to 
closely monitor the impact of the UK’s Psychoactive Substances Act, 2016 on the hidden 
web drug supply.   
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Table 1: The number of online shops found under each key words on search engine’s 
Google™ and Bing™. 
Key word (Buy +) Number of online shops 
Legal highs 25 
Research chemicals 35 
Bath salts 10 
Party pills 24 
Herbal highs 19 
TOTAL 113 
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Table 2: Number of vendors selling NPS in each cryptomarket from October 2015 to 
October 2016.  
Cryptomarkets Number of vendors   
 Oct 
2015 
Dec 
2015 
Feb 
2016 
Apr 
2016 
Jun 
2016 
Aug 
2016 
Oct 
2016 
Abraxas 88 CLOSED - - - - - 
Nucleus 67 84 86 92 CLOSED - - 
Middle Earth 51 CLOSED - - - - - 
Alphabay 44 83 96 122 134 157 244 
Valhalla 21 28 34 31 37 49 50 
Dream Market 16 67 67 35 111 117 120 
East India 
Company 
11 24 CLOSED - - - - 
CryptoMarket/SR3 5 15 14 17 15 14 15 
HANSA 5 7 10 11 26 27 41 
DrD’s Market 3 6 12 15 DOWN 13 CLOSED 
OUTLAW 3 9 5 3 5 7 5 
Python Market 2 5 8 9 8 8 DOWN 
Acas - 4 11 CLOSED - - - 
TheRealDeal - 1 2 5 5 7 DOWN 
Oasis - - 4 1 8 14 DOWN 
Apple - - - 7 7 10 11 
T*cka - - - 3 5 8 7 
Detox - - - 2 4 3 5 
Leo - - - - 4 5 8 
Acropolis - - - - 2 3 4 
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Minerva - - - - - 2 DOWN 
TradeRoute - - - - - - 6 
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Table 3: Summary of descriptives of the cryptomarkets 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Uncontrolled” substances are those not controlled under the UK Misuse of Drugs Act, 1971, before the implementation of the Psychoactive Substances Act, 
2016 on the 26th of May 2016. 
 Oct 2015 Dec 2015 Feb 2016 Apr 2016 June 2016 Aug 2016 Oct 2016 
ALL NPS        
Cryptomarket 
leader (no. of 
vendors selling 
NPS) 
Abraxas  
(88) 
Nucleus  
(84) 
AlphaBay  
(96) 
AlphaBay 
(122) 
AlphaBay  
(134) 
AlphaBay 
(157) 
AlphaBay 
(244) 
Total no. of 
vendors selling 
NPS 
212 214 233 256 262 307 370 
Total no. of unique 
NPS advertised 
94 119 158 161 163 169 182 
Total no. of 
vendors selling 
NPS alone or with 
prescription drugs 
107 98 88 108 95 114 138 
Total no. of NPS 
listings 
759 840 958 1187 1311 1322 1763 
Leading NPS 
category 
Phenethylamines Cathinones Phenethylamines Cathinones Phenethylamines Cathinones Cathinones 
UNCONTROLLED (% of total number of NPS)    
Total no. of NPS 
sold  
26 (27.7) 37 (31.1) 46 (29.1) 45 (28.0) N/A N/A 
 
N/A 
Total no. of NPS 
listings  
142 (18.9) 185 (22.0) 243 (25.4) 303 (25.5) N/A N/A N/A 
Leading NPS 
category 
Synthetic 
cannabinoids 
Synthetic 
cannabinoids 
Synthetic 
cannabinoids 
Synthetic 
cannabinoids 
N/A N/A N/A 
